QYB timeline
Every QYB batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| QYB-2607-L5615 | PT-141 (Bremelanotide) | 07 Jul 2026 | 2026-Q3 | 10 | 99.78 | 0.76 | 99.90 | +0.12 | |
| QYB-2605-H4298 | Ipamorelin | 01 May 2026 | 2026-Q3 | 5 | 99.93 | 0.00 | 99.90 | -0.03 | |
| QYB-2604-B5660 | Retatrutide | 25 Apr 2026 | 2026-Q3 | 10 | 98.58 | 1.23 | 99.19 | +0.61 | |
| QYB-2603-A6476 | Enclomiphene citrate | 02 Mar 2026 | 2026-Q1 | 8 | 99.66 | 0.78 | 99.90 | +0.24 | |
| QYB-2602-X5162 | GHRP-6 | 20 Feb 2026 | 2026-Q1 | 1 | 99.71 | n<2 | 99.86 | +0.15 | |
| QYB-2602-R6263 | Retatrutide | 20 Feb 2026 | 2026-Q2 | 10 | 98.23 | 1.81 | 98.60 | +0.37 | |
| QYB-2602-G6308 | Retatrutide | 15 Feb 2026 | 2026-Q3 | 4 | 98.32 | 0.72 | 99.02 | +0.70 | |
| QYB-2601-D4733 | BPC-157 | 27 Jan 2026 | 2026-Q2 | 8 | 99.93 | 0.40 | 99.90 | -0.03 | |
| QYB-2601-H6381 | BPC-157 | 24 Jan 2026 | 2026-Q2 | 11 | 99.93 | 0.45 | 99.90 | -0.03 | |
| QYB-2601-V5169 | Oxytocin | 17 Jan 2026 | 2026-Q2 | 2 | 99.77 | 0.33 | 99.90 | +0.13 | |
| QYB-2512-R5934 | TB-500 | 27 Dec 2025 | 2026-Q1 | 7 | 99.93 | 0.25 | 99.90 | -0.03 | |
| QYB-2512-Y6648 | IGF-1 LR3 | 20 Dec 2025 | 2026-Q1 | 3 | 98.65 | 0.55 | 99.78 | +1.13 | |
| QYB-2512-A5720 | Humanin (HNG) | 14 Dec 2025 | 2026-Q1 | 3 | 99.47 | 0.50 | 99.33 | -0.14 | |
| QYB-2512-X5662 | Kisspeptin-10 | 07 Dec 2025 | 2026-Q2 | 9 | 99.93 | 0.53 | 99.90 | -0.03 | |
| QYB-2512-H5402 | SS-31 (Elamipretide) | 05 Dec 2025 | 2026-Q2 | 6 | 99.58 | 0.95 | 99.90 | +0.32 | |
| QYB-2511-Y5015 | ARA-290 | 09 Nov 2025 | 2025-Q4 | 5 | 99.83 | 1.47 | 99.90 | +0.07 | |
| QYB-2511-H6699 | TB-500 | 07 Nov 2025 | 2026-Q1 | 14 | 99.39 | 0.78 | 99.52 | +0.13 | |
| QYB-2511-V5143 | Liraglutide | 05 Nov 2025 | 2026-Q2 | 8 | 99.17 | 1.22 | 99.71 | +0.54 | |
| QYB-2511-V6148 | Thymosin α1 | 04 Nov 2025 | 2026-Q1 | 1 | 99.44 | n<2 | 100.50 | +1.06 | |
| QYB-2510-C6129 | 5-Amino-1MQ | 11 Oct 2025 | 2026-Q1 | 6 | 99.60 | 0.80 | 99.90 | +0.30 | |
| QYB-2510-D4955 | GHRP-2 | 07 Oct 2025 | 2025-Q4 | 13 | 99.26 | 0.97 | 99.80 | +0.54 | |
| QYB-2510-R5348 | BPC-157 | 06 Oct 2025 | 2026-Q1 | 2 | 99.67 | 0.21 | 99.90 | +0.23 | |
| QYB-2508-E6017 | AOD-9604 | 20 Aug 2025 | 2026-Q1 | 8 | 99.64 | 1.20 | 99.84 | +0.20 | |
| QYB-2508-M5929 | BPC-157 | 18 Aug 2025 | 2025-Q4 | 4 | 99.78 | 0.38 | 99.90 | +0.12 | |
| QYB-2507-T5368 | Tirzepatide | 28 Jul 2025 | 2025-Q4 | 4 | 99.44 | 0.68 | 99.79 | +0.35 | |
| QYB-2507-R5467 | Retatrutide | 28 Jul 2025 | 2025-Q4 | 10 | 98.29 | 1.76 | 99.22 | +0.93 | |
| QYB-2506-S6277 | SS-31 (Elamipretide) | 28 Jun 2025 | 2025-Q3 | 1 | 99.88 | n<2 | 99.90 | +0.02 | |
| QYB-2506-B4999 | BPC-157 | 08 Jun 2025 | 2025-Q4 | 10 | 99.93 | 0.03 | 100.50 | +0.57 | |
| QYB-2505-R6399 | MK-677 (Ibutamoren mesylate) | 14 May 2025 | 2025-Q3 | 1 | 99.75 | n<2 | 99.24 | -0.51 | |
| QYB-2505-C5547 | CJC-1295 (no DAC) | 08 May 2025 | 2025-Q3 | 5 | 98.86 | 1.19 | 99.89 | +1.03 | |
| QYB-2505-U5789 | Semaglutide | 03 May 2025 | 2025-Q3 | 4 | 99.12 | 0.58 | 99.90 | +0.78 | |
| QYB-2504-H5763 | GHRP-6 | 22 Apr 2025 | 2025-Q2 | 1 | 99.61 | n<2 | 99.90 | +0.29 | |
| QYB-2503-W6005 | MK-677 (Ibutamoren mesylate) | 24 Mar 2025 | 2025-Q3 | 2 | 98.91 | 0.35 | 98.78 | -0.13 | SHARED BULK |
| QYB-2503-Y6694 | Dihexa | 02 Mar 2025 | 2025-Q3 | 12 | 99.93 | 0.26 | 99.90 | -0.03 | |
| QYB-2502-V5083 | Pemvidutide | 28 Feb 2025 | 2025-Q3 | 9 | 98.93 | 1.98 | 99.00 | +0.07 | |
| QYB-2502-G6252 | Survodutide | 02 Feb 2025 | 2025-Q3 | 3 | 98.61 | 0.57 | 99.87 | +1.26 | |
| QYB-2501-T5609 | Selank | 14 Jan 2025 | 2025-Q2 | 2 | 99.85 | 0.16 | 99.90 | +0.05 | |
| QYB-2501-C5919 | N-Acetyl Semax Amide | 06 Jan 2025 | 2025-Q2 | 4 | 99.85 | 0.23 | 99.90 | +0.05 | |
| QYB-2411-G5768 | N-Acetyl Semax Amide | 22 Nov 2024 | 2025-Q2 | 6 | 99.90 | 0.59 | 99.90 | 0.00 | |
| QYB-2410-S5114 | GHRP-6 | 31 Oct 2024 | 2024-Q4 | 7 | 99.51 | 0.51 | 99.89 | +0.38 | |
| QYB-2410-V5649 | Semaglutide | 16 Oct 2024 | 2025-Q1 | 6 | 99.67 | 0.88 | 99.90 | +0.23 | |
| QYB-2408-A5377 | Ipamorelin | 09 Aug 2024 | 2025-Q1 | 7 | 99.93 | 0.27 | 99.90 | -0.03 | |
| QYB-2408-A5127 | TB-500 | 08 Aug 2024 | 2025-Q1 | 10 | 99.51 | 1.34 | 99.90 | +0.39 | |
| QYB-2407-E5509 | Ipamorelin | 27 Jul 2024 | 2024-Q4 | 7 | 99.93 | 1.31 | 99.90 | -0.03 | |
| QYB-2407-J4707 | TB-500 | 11 Jul 2024 | 2024-Q3 | 3 | 99.60 | 0.50 | 99.90 | +0.30 | |
| QYB-2404-N6056 | AOD-9604 | 10 Apr 2024 | 2024-Q2 | 5 | 99.93 | 0.47 | 99.90 | -0.03 | |
| QYB-2404-W5163 | Sermorelin | 06 Apr 2024 | 2024-Q2 | 12 | 99.35 | 1.05 | 99.90 | +0.55 | |
| QYB-2403-T5291 | Tirzepatide | 13 Mar 2024 | 2024-Q3 | 1 | 98.88 | n<2 | 99.42 | +0.54 | |
| QYB-2402-P5428 | Melanotan II | 21 Feb 2024 | 2024-Q2 | 11 | 99.87 | 0.59 | 99.90 | +0.03 | |
| QYB-2402-J5424 | Tirzepatide | 13 Feb 2024 | 2024-Q1 | 4 | 99.10 | 1.76 | 99.82 | +0.72 | |
| QYB-2312-K5632 | Retatrutide | 05 Dec 2023 | 2024-Q2 | 8 | 98.29 | 1.45 | 98.97 | +0.68 | SHARED BULK |
| QYB-2311-U4777 | Semaglutide | 10 Nov 2023 | 2024-Q2 | 12 | 99.06 | 1.35 | 99.68 | +0.62 |